I-Corps: Novel Catalytic Ozonation Processes for Advanced Water and Wastewater Treatment
I-Corps:用于高级水和废水处理的新型催化臭氧化工艺
基本信息
- 批准号:2309263
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2024-09-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this I-Corps project is the development of plasmon-enhanced catalytic ozonation innovations to provide a cost-effective solution to the water quality challenge associated with increasing recalcitrant organic pollutants in the source water. The system adaptability of the photo-assisted catalytic ozonation process could make it a competitive treatment technology that can accommodate to both current available centralized infrastructure and emerging distributed/reuse facilities. Thus, a successful commercialization effort will help address a significant societal challenge: increasing demand for clean water under the stress of rapid population growth, shortage of fresh water sources, climate change, impaired water sources, and aging infrastructure.This I-Corps project is based on the development of an innovation of a novel catalytic ozonation process mediated by plasmonic metal catalysts for the removal of recalcitrant organic pollutants from water. Effective degradation of representative pollutants was achieved in both synthetic solutions and real environmental waters with low energy consumption and byproduct formation. The superior treatment performance together with the low material costs, mature and facile synthesis methods, and good recyclability of the catalysts, all demonstrates the great commercialization potential of plasmon-enhanced catalytic ozonation processes. It is estimated that one-third of all counties in the contiguous U.S. will face high risk of water shortage by 2050 and a market worth of $128.78 billion is forecast for water and wastewater treatment technologies by 2029. Contamination of aquatic environment with thousands of organic chemicals, which often cannot be effectively removed in conventional water and wastewater treatment, is a key water quality problem.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
该I-Corps项目的更广泛的影响/商业潜力是发展等离子增强的催化臭氧创新,以针对与源水中的旋转固有有机污染物相关的水质挑战提供了具有成本效益的解决方案。照片辅助催化臭氧化过程的系统适应性可以使其成为一种竞争性的治疗技术,可以适应当前可用的集中基础设施和新兴的分布式/再利用设施。 Thus, a successful commercialization effort will help address a significant societal challenge: increasing demand for clean water under the stress of rapid population growth, shortage of fresh water sources, climate change, impaired water sources, and aging infrastructure.This I-Corps project is based on the development of an innovation of a novel catalytic ozonation process mediated by plasmonic metal catalysts for the removal of recalcitrant organic pollutants from water.在能源消耗低和副产物形成的合成溶液和真实环境水中都实现了代表性污染物的有效降解。优越的治疗性能以及材料成本低,成熟和易于合成方法以及催化剂的良好可回收性,都证明了等离子体增强催化臭氧化过程的巨大商业化潜力。据估计,到2050年,美国连续的三分之一的县将面临高水位的高风险,到2029年,水和废水处理技术的价值为1,287.8亿美元。并被认为是通过基金会的知识分子优点和更广泛的影响审查标准来评估值得支持的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tingting Wu其他文献
High-Resolution Functional Profiling of a Gammaherpesvirus RTA Locus in the Context of the Viral Genome (cid:1) †
病毒基因组背景下伽马疱疹病毒 RTA 基因座的高分辨率功能分析 (cid:1) †
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
V. Arumugaswami;R. Sitapara;Seungmin Hwang;M. Song;T.;Nancy Su;E. Sue;Vidhya Kanagavel;Fangfang Xing;Xiaolin Zhang;Ming;H. Deng;Tingting Wu;S. Kanagavel;Lulu Zhang;S. Dandekar;J. Papp;R. Sun - 通讯作者:
R. Sun
Repeated-root constacyclic codes of length 6lmpn
长度为 6lmpn 的重根常循环码
- DOI:
10.3934/amc.2021044 - 发表时间:
2023 - 期刊:
- 影响因子:0.9
- 作者:
Tingting Wu;Shixin Zhu;Li Liu;Lanqiang Li - 通讯作者:
Lanqiang Li
Improved propylene/propane separation performance under high temperature and pressures on in-situ ligand-doped ZIF-8 membranes
提高原位配体掺杂 ZIF-8 膜在高温高压下的丙烯/丙烷分离性能
- DOI:
10.1016/j.memsci.2020.118655 - 发表时间:
2021 - 期刊:
- 影响因子:9.5
- 作者:
Eryue Song;Kaifeng Wei;Haiqian Lian;Jingxian Hua;Hongxu Tao;Tingting Wu;Yichang Pan;Weihong Xing - 通讯作者:
Weihong Xing
Fixed-point proximity algorithms solving an incomplete Fourier transform model for seismic wavefield modeling
定点邻近算法求解地震波场建模的不完全傅立叶变换模型
- DOI:
10.1016/j.cam.2020.113208 - 发表时间:
2021-03 - 期刊:
- 影响因子:0
- 作者:
Yuesheng Xu;Lixin Shen;Tingting Wu - 通讯作者:
Tingting Wu
Finite volume method for solving the stochastic Helmholtz equation
求解随机亥姆霍兹方程的有限体积法
- DOI:
10.1186/s13662-019-2011-x - 发表时间:
2019-03 - 期刊:
- 影响因子:4.1
- 作者:
Ruimin Xu;Tingting Wu - 通讯作者:
Tingting Wu
Tingting Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tingting Wu', 18)}}的其他基金
Plasmon-Enhanced Catalytic Ozonation for Water Treatment and Reuse
用于水处理和再利用的等离激元增强催化臭氧化
- 批准号:
1606117 - 财政年份:2016
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
相似国自然基金
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
- 批准号:82304677
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
- 批准号:82304658
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
- 批准号:32171163
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance
光滑念珠菌抗真菌药物耐药性中蛋白激酶的功能和转录组分析
- 批准号:
10643423 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:
10659658 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome
Jansen de Vries 综合征中发现的含有 PPM1D 截短突变的 iPSC 衍生的谷氨酸能神经元的分子分析
- 批准号:
10573782 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Chromatin regulators of stemness and therapy resistance in rhabdomyosarcoma
横纹肌肉瘤干性和治疗耐药性的染色质调节因子
- 批准号:
10622041 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别: